|
시장보고서
상품코드
1507218
RWE(Real World Evidence) 애플리케이션용 유전체 데이터 세트 시장, 점유율, 규모, 동향, 산업 분석 보고서 : 용도별, 지출별, 최종사용자별, 유전체 데이터 유형별, 환자 기록별, 데이터 유형별, 지역별, 부문별 예측(2024-2032년)Genomic Data Set for Real World Evidence (RWE) Applications Market Share, Size, Trends, Industry Analysis Report, By Application; By Spend; By End-Users; By Genomic Data Type; By Patient Records; By Data Type; By Region; Segment Forecast, 2024 - 2032 |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
Polaris Market Research의 최신 조사에 따르면, 세계 RWE(Real World Evidence) 애플리케이션용 유전체 데이터 세트 시장 규모는 2032년까지 17억 460만 달러에 달할 것으로 예상됩니다. 이 보고서는 현재 시장 역학에 대한 자세한 인사이트와 향후 시장 성장에 대한 분석을 제공합니다.
세계 RWE(Real World Evidence) 애플리케이션용 유전체 데이터 세트 시장은 첨단 게놈 분석, 헬스케어 분석, 디지털 기술의 융합에 힘입어 괄목할 만한 성장과 혁신을 거듭하고 있습니다. 이 역동적인 시장은 질병의 유전적 기반에 대한 중요한 인사이트를 제공하고 환자 맞춤형 치료를 촉진함으로써 의료 연구, 치료 및 결과에 혁명을 일으킬 수 있는 잠재력을 가지고 있습니다. 주요 성장 요인은 정밀의료의 채택이 확대되고 있다는 점입니다. 유전체 데이터를 활용하여 표적 치료 및 진단 도구를 개발함으로써 보다 효과적인 치료, 부작용 감소, 환자 예후 개선으로 이어질 수 있습니다.
시장을 이끄는 또 다른 중요한 요소는 집단건강관리에 대한 관심이 높아지고 있다는 점입니다. 유전체 데이터는 집단 내 유전적 변이에 대한 귀중한 인사이트를 제공하여 질병 예방, 조기 발견 및 표적화된 개입을 위한 선제적 조치를 가능하게 합니다. 대규모 유전체 데이터 세트를 통해 공중보건 기관은 고위험군을 식별하고, 맞춤형 검진 프로그램을 개발하며, 효과적인 공중보건 전략을 실행할 수 있습니다. 그러나 이 시장은 기밀성이 높은 유전자 정보와 관련된 프라이버시 우려와 보안 문제 등의 도전에 직면해 있습니다. 이러한 문제를 해결하고 유전체 데이터 수집 및 분석에 참여하는 환자, 연구자 및 이해관계자들에게 신뢰를 주기 위해서는 규제 프레임워크와 강력한 데이터 보호 조치가 필수적입니다.
변혁적 잠재력에도 불구하고, 윤리적 고려사항은 RWE 적용을 위해 전 세계 유전체 데이터 세트를 충분히 활용하는 데 있어 걸림돌이 되고 있습니다. 데이터 가용성과 프라이버시 보호의 균형을 맞추기 위해서는 책임감 있는 데이터 사용, 사전 동의, 투명한 데이터 공유 관행을 보장하기 위한 견고한 거버넌스 프레임워크, 표준, 프로토콜을 확립해야 합니다. 개인의 권리를 보호하고, 사회로부터의 신뢰를 강화하며, 유전체 데이터에 대한 공평한 접근을 보장하는 것은 이 분야의 윤리적이고 지속가능한 성장을 위해 매우 중요합니다.
RWE(Real World Evidence) 애플리케이션용 유전체 데이터 세트 시장 보고서 하이라이트
종양학은 RWE(Real World Evidence)를 위한 유전체 데이터 세트 시장을 장악하고 있으며, 개인화된 암 개입과 치료의 정확성을 위해 게놈 지식을 활용하고 있습니다.
서비스/CRO와 같은 수익이 예측 기간 동안 RWE를 위한 유전체 데이터 세트 시장을 주도하고 개인 맞춤형 의료의 발전과 시장 성장을 촉진할 것으로 예상됩니다.
북미는 선진적인 인프라, 탄탄한 연구개발, 유전체 의학에 대한 노력으로 2022년 세계 시장을 장악하고, RWE(Real World Evidence)의 응용을 형성하고 있습니다.
목차
제1장 소개
제2장 주요 요약
제3장 조사 방법
제4장 세계의 RWE(Real World Evidence) 애플리케이션용 유전체 데이터 세트 시장 분석
- RWE(Real World Evidence) 애플리케이션용 유전체 데이터 세트 - 업계 현황
- RWE(Real World Evidence) 애플리케이션용 유전체 데이터 세트 시장 역학
- 성장 촉진요인과 기회
- 유전체 기술의 진보
- 정밀의료와 개인화된 헬스케어
- 성장 억제요인과 과제
- 데이터 프라이버시와 보안에 관한 우려
- 성장 촉진요인과 기회
- Porter's Five Forces 분석
- PESTLE 분석
- RWE(Real World Evidence) 애플리케이션용 유전체 데이터 세트 업계 동향
- COVID-19의 영향 분석
제5장 세계의 RWE(Real World Evidence) 애플리케이션용 유전체 데이터 세트 시장 : 네트워크 모델별
- 주요 조사 결과
- 소개
- 종양학
- 심혈관
- 신경학
- 면역학
- 기타
제6장 세계의 RWE(Real World Evidence) 애플리케이션용 유전체 데이터 세트 시장 : 지출별
- 주요 조사 결과
- 소개
- RW 유전체 데이터
- RW 소프트웨어
- 서비스/CRO 유사 매출
- 데이터 생성
- 기타
제7장 세계의 RWE(Real World Evidence) 애플리케이션용 유전체 데이터 세트 시장 : 데이터 타이퍼별
- 주요 조사 결과
- 소개
- 바이오의약품
- 기타 부문
제8장 세계의 RWE(Real World Evidence) 애플리케이션용 유전체 데이터 세트 시장 : 유전체 데이터 유형별
- 주요 조사 결과
- 소개
- 완전 오믹스 배열 데이터
- 기타
제9장 세계의 RWE(Real World Evidence) 애플리케이션용 유전체 데이터 세트 시장 : 환자 기록별
- 주요 조사 결과
- 소개
- 개별화
- 집계
제10장 세계의 RWE(Real World Evidence) 애플리케이션용 유전체 데이터 세트 시장 : 데이터 유형별
- 주요 조사 결과
- 소개
- DNA(유전자)
- RNA(전사체)
- 단백질(프로테옴)
- 대사물(대사물)
- 기타
제11장 세계의 RWE(Real World Evidence) 애플리케이션용 유전체 데이터 세트 시장 : 지역별
- 주요 조사 결과
- 소개
- RWE(Real World Evidence) 애플리케이션용 유전체 데이터 세트 시장 평가 : 지역별, 2019-2032년
- 북미
- 북미 : 네트워크 모델별, 2019-2032년
- 북미 : 유전체 데이터 유형별, 2019-2032년
- 북미 : 지출별, 2019-2032년
- 북미 : 환자 기록별, 2019-2032년
- 북미 : 데이터 타이퍼별, 2019-2032년
- 북미 : 데이터 유형별, 2019-2032년
- 미국
- 캐나다
- 유럽
- 유럽 : 네트워크 모델별, 2019-2032년
- 유럽 : 유전체 데이터 유형별, 2019-2032년
- 유럽 : 지출별, 2019-2032년
- 유럽 : 환자 기록별, 2019-2032년
- 유럽 : 데이터 타이퍼별, 2019-2032년
- 유럽 : 데이터 유형별,2019-2032
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 아시아태평양
- 아시아태평양 : 네트워크 모델별, 2019-2032년
- 아시아태평양 : 유전체 데이터 유형별, 2019-2032년
- 아시아태평양 : 지출별, 2019-2032년
- 아시아태평양 : 환자 기록별, 2019-2032년
- 아시아태평양 : 데이터 타이퍼별, 2019-2032년
- 아시아태평양 : 데이터 유형별,2019-2032
- 중국
- 인도
- 일본
- 말레이시아
- 인도네시아
- 한국
- 중동 및 아프리카
- 중동 및 아프리카 : 네트워크 모델별, 2019-2032년
- 중동 및 아프리카 : 유전체 데이터 유형별, 2019-2032년
- 중동 및 아프리카 : 지출별, 2019-2032년
- 중동 및 아프리카 : 환자 기록별, 2019-2032년
- 중동 및 아프리카 : 데이터 타이퍼별, 2019-2032년
- 중동 및 아프리카 : 데이터 유형별,2019-2032
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 남아프리카공화국
- 라틴아메리카
- 라틴아메리카 : 네트워크 모델별, 2019-2032년
- 라틴아메리카 : 유전체 데이터 유형별, 2019-2032년
- 라틴아메리카 : 지출별, 2019-2032년
- 라틴아메리카 : 환자 기록별, 2019-2032년
- 라틴아메리카 : 데이터 타이퍼별, 2019-2032년
- 라틴아메리카 : 데이터 유형별,2019-2032
- 멕시코
- 브라질
- 아르헨티나
제12장 경쟁 상황
- 확대와 인수 분석
- 확대
- 인수
- 제휴/협업/합의/공개
제13장 기업 개요
- Caris Life Sciences
- Foundation Medicine, Inc
- Guardant Health
- HealthVerity, Inc
- Invitae Corporation
- IQVIA Inc
- Komodo Health, Inc
- LabCorp
- Myriad Genetics Inc
- Natera, Inc
- Ovation.io
- TEMPUS
The global genomic data set for real-world evidence (RWE) applications market size is expected to reach USD 1,704.60 million by 2032, according to a new study by Polaris Market Research. The report "Genomic Data Set for Real World Evidence (RWE) Applications Market Share, Size, Trends, Industry Analysis Report, By Application; By Spend; By End-Users; By Genomic Data Type; By Patient Records; By Data Type; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The global genomic data set for the Real-World Evidence (RWE) applications market is undergoing significant growth and innovation, driven by the convergence of advanced genomics, healthcare analytics, and digital technologies. This dynamic market has the potential to revolutionize healthcare research, treatment, and outcomes by offering critical insights into the genetic basis of diseases and facilitating personalized patient care. A key growth driver is the escalating adoption of precision medicine, wherein genomic data is leveraged to develop targeted therapies and diagnostic tools, leading to more effective treatments, reduced adverse reactions, and improved patient outcomes.
Another pivotal factor propelling the market is the increasing focus on population health management. Genomic data contributes valuable insights into genetic variations within populations, enabling proactive measures for disease prevention, early detection, and targeted interventions. Large-scale genomic datasets empower public health organizations to identify high-risk populations, develop tailored screening programs, and implement effective public health strategies. However, the market faces challenges such as privacy concerns and security issues associated with sensitive genetic information. Regulatory frameworks and robust data protection measures are essential to address these concerns, instilling confidence in patients, researchers, and stakeholders involved in genomic data collection and analysis.
Despite its transformative potential, ethical considerations pose a restraint in fully harnessing the global genomic data set for RWE applications. Balancing data accessibility with privacy protection requires the establishment of robust governance frameworks, standards, and protocols to ensure responsible data use, informed consent, and transparent data-sharing practices. Strengthening public trust and ensuring equitable access to genomic data while safeguarding individual rights are crucial for the ethical and sustainable growth of this field.
Genomic Data Set for Real World Evidence (RWE) Applications Market Report Highlights
Oncology dominates the Genomic Data Set for the Real World Evidence market and leverages genomic insights for personalized cancer interventions and treatment precision.
Services/CRO-like revenues drive Genomic Data Set for the RWE market over a forecasted period, fostering personalized medicine advancements and market growth.
North America dominated the global market in 2022 due to advanced infrastructure, robust R&D, and genomic medicine initiatives, shaping real-world evidence applications.
The global key market players include TEMPUS, Guardant Health, Foundation Medicine, Inc., IQVIA Inc., HealthVerity, Inc., Komodo Health, Inc., Caris Life Sciences, LabCorp, Invitae Corporation, Myriad Genetics Inc., Natera, Inc., Ovation.io
Polaris Market Research has segmented the Genomic Data Set for Real World Evidence (RWE) Applications market report based on application, spend, end-users, genomic data type, patient records, data type, and region:
Genomic Data Set for Real World Evidence (RWE) Applications, Application Outlook (Revenue - USD Million, 2019 - 2032)
- Oncology
- Cardiovascular
- Neurology
- Immunology
- Others
Genomic Data Set for Real World Evidence (RWE) Applications, Spend Outlook (Revenue - USD Million, 2019 - 2032)
- RW genomic data
- RW software
- Services/ CRO-like revenues
- Data Generation
- Others
Genomic Data Set for Real World Evidence (RWE) Applications, End-Users Outlook (Revenue - USD Million, 2019 - 2032)
- Biopharma
- Other Segments
Genomic Data Set for Real World Evidence (RWE) Applications, Genomic Data Type Outlook (Revenue - USD Million, 2019 - 2032)
- Full 'omic sequence data
- Others
Genomic Data Set for Real World Evidence (RWE) Applications, Patient Records Outlook (Revenue - USD Million, 2019 - 2032)
- Individualized
- Aggregate
Genomic Data Set for Real World Evidence (RWE) Applications, Data Type Outlook (Revenue - USD Million, 2019 - 2032)
- DNA (genetic)
- RNA (transcriptome)
- Protein (proteome)
- Metabolite (metabolite)
- Others
Genomic Data Set for Real World Evidence (RWE) Applications, Regional Outlook (Revenue - USD Million, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Austria
- Netherlands
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Australia
- Rest of APAC
- Latin America
- Argentina
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
- Rest of MEA
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Genomic Data Set for Real World Evidence (RWE) Applications Market Insights
- 4.1. Genomic Data Set for Real World Evidence (RWE) Applications - Industry Snapshot
- 4.2. Genomic Data Set for Real World Evidence (RWE) Applications Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Advancements in genomic technologies
- 4.2.1.2. Precision medicine and personalized healthcare
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Data privacy and security concerns
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTLE Analysis
- 4.5. Genomic Data Set for Real World Evidence (RWE) Applications Industry Trends
- 4.6. COVID-19 Impact Analysis
5. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
- 5.3. Oncology
- 5.3.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Oncology, by Region, 2019-2032 (USD Million)
- 5.4. Cardiovascular
- 5.4.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Cardiovascular, by Region, 2019-2032 (USD Million)
- 5.5. Neurology
- 5.5.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Neurology, by Region, 2019-2032 (USD Million)
- 5.6. Immunology
- 5.6.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Immunology, by Region, 2019-2032 (USD Million)
- 5.7. Others
- 5.7.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Others, by Region, 2019-2032 (USD Million)
6. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
- 6.3. RW genomic data
- 6.3.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by RW genomic data, by Region, 2019-2032 (USD Million)
- 6.4. RW software
- 6.4.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by RW software, by Region, 2019-2032 (USD Million)
- 6.5. Services/ CRO-like revenues
- 6.5.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Services/ CRO-like revenues, by Region, 2019-2032 (USD Million)
- 6.6. Data Generation
- 6.6.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data Generation, by Region, 2019-2032 (USD Million)
- 6.7. Others
- 6.7.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Others, by Region, 2019-2032 (USD Million)
7. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
- 7.3. Biopharma
- 7.3.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Biopharma, by Region, 2019-2032 (USD Million)
- 7.4. Other Segments
- 7.4.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Other Segments, by Region, 2019-2032 (USD Million)
8. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
- 8.3. Full 'omic sequence data
- 8.3.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Full 'omic sequence data, by Region, 2019-2032 (USD Million)
- 8.4. Others
- 8.4.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Others, by Region, 2019-2032 (USD Million)
9. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
- 9.3. Individualized
- 9.3.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Individualized, by Region, 2019-2032 (USD Million)
- 9.4. Aggregate
- 9.4.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Aggregate, by Region, 2019-2032 (USD Million)
10. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type
- 10.1. Key Findings
- 10.2. Introduction
- 10.2.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
- 10.3. DNA (genetic)
- 10.3.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by DNA (genetic), by Region, 2019-2032 (USD Million)
- 10.4. RNA (transcriptome)
- 10.4.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by RNA (transcriptome), by Region, 2019-2032 (USD Million)
- 10.5. Protein (proteome)
- 10.5.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Protein (proteome), by Region, 2019-2032 (USD Million)
- 10.6. Metabolite (metabolite)
- 10.6.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Metabolite (metabolite), by Region, 2019-2032 (USD Million)
- 10.7. Others
- 10.7.1. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Others, by Region, 2019-2032 (USD Million)
11. Global Genomic Data Set for Real World Evidence (RWE) Applications Market, by Geography
- 11.1. Key findings
- 11.2. Introduction
- 11.2.1. Genomic Data Set for Real World Evidence (RWE) Applications Market Assessment, By Geography, 2019-2032 (USD Million)
- 11.3. Genomic Data Set for Real World Evidence (RWE) Applications Market - North America
- 11.3.1. North America: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
- 11.3.2. North America: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
- 11.3.3. North America: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
- 11.3.4. North America: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
- 11.3.5. North America: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
- 11.3.6. North America: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
- 11.3.7. Genomic Data Set for Real World Evidence (RWE) Applications Market - U.S.
- 11.3.7.1. U.S.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
- 11.3.7.2. U.S.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
- 11.3.7.3. U.S.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
- 11.3.7.4. U.S.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
- 11.3.7.5. U.S.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
- 11.3.7.6. U.S.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
- 11.3.8. Genomic Data Set for Real World Evidence (RWE) Applications Market - Canada
- 11.3.8.1. Canada: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
- 11.3.8.2. Canada.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
- 11.3.8.3. Canada: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
- 11.3.8.4. Canada: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
- 11.3.8.5. Canada: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
- 11.3.8.6. Canada: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
- 11.4. Genomic Data Set for Real World Evidence (RWE) Applications Market - Europe
- 11.4.1. Europe: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
- 11.4.2. Europe.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
- 11.4.3. Europe: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
- 11.4.4. Europe: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
- 11.4.5. Europe: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
- 11.4.6. Europe: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
- 11.4.7. Genomic Data Set for Real World Evidence (RWE) Applications Market - UK
- 11.4.7.1. UK: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
- 11.4.7.2. UK.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
- 11.4.7.3. UK: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
- 11.4.7.4. UK: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
- 11.4.7.5. UK: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
- 11.4.7.6. UK: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
- 11.4.8. Genomic Data Set for Real World Evidence (RWE) Applications Market - France
- 11.4.8.1. France: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
- 11.4.8.2. France.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
- 11.4.8.3. France: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
- 11.4.8.4. France: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
- 11.4.8.5. France: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
- 11.4.8.6. France: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
- 11.4.9. Genomic Data Set for Real World Evidence (RWE) Applications Market - Germany
- 11.4.9.1. Germany: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
- 11.4.9.2. Germany.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
- 11.4.9.3. Germany: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
- 11.4.9.4. Germany: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
- 11.4.9.5. Germany: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
- 11.4.9.6. Germany: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
- 11.4.10. Genomic Data Set for Real World Evidence (RWE) Applications Market - Italy
- 11.4.10.1. Italy: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
- 11.4.10.2. Italy.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
- 11.4.10.3. Italy: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
- 11.4.10.4. Italy: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
- 11.4.10.5. Italy: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
- 11.4.10.6. Italy: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
- 11.4.11. Genomic Data Set for Real World Evidence (RWE) Applications Market - Spain
- 11.4.11.1. Spain: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
- 11.4.11.2. Spain.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
- 11.4.11.3. Spain: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
- 11.4.11.4. Spain: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
- 11.4.11.5. Spain: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
- 11.4.11.6. Spain: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
- 11.4.12. Genomic Data Set for Real World Evidence (RWE) Applications Market - Netherlands
- 11.4.12.1. Netherlands: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
- 11.4.12.2. Netherlands.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
- 11.4.12.3. Netherlands: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
- 11.4.12.4. Netherlands: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
- 11.4.12.5. Netherlands: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
- 11.4.12.6. Netherlands: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
- 11.4.13. Genomic Data Set for Real World Evidence (RWE) Applications Market - Russia
- 11.4.13.1. Russia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
- 11.4.13.2. Russia.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
- 11.4.13.3. Russia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
- 11.4.13.4. Russia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
- 11.4.13.5. Russia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
- 11.4.13.6. Russia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
- 11.5. Genomic Data Set for Real World Evidence (RWE) Applications Market - Asia Pacific
- 11.5.1. Asia Pacific: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
- 11.5.2. Asia Pacific.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
- 11.5.3. Asia Pacific: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
- 11.5.4. Asia Pacific: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
- 11.5.5. Asia Pacific: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
- 11.5.6. Asia Pacific: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
- 11.5.7. Genomic Data Set for Real World Evidence (RWE) Applications Market - China
- 11.5.7.1. China: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
- 11.5.7.2. China.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
- 11.5.7.3. China: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
- 11.5.7.4. China: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
- 11.5.7.5. China: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
- 11.5.7.6. China: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
- 11.5.8. Genomic Data Set for Real World Evidence (RWE) Applications Market - India
- 11.5.8.1. India: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
- 11.5.8.2. India.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
- 11.5.8.3. India: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
- 11.5.8.4. India: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
- 11.5.8.5. India: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
- 11.5.8.6. India: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
- 11.5.9. Genomic Data Set for Real World Evidence (RWE) Applications Market - Japan
- 11.5.9.1. Japan: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
- 11.5.9.2. Japan.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
- 11.5.9.3. Japan: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
- 11.5.9.4. Japan: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
- 11.5.9.5. Japan: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
- 11.5.9.6. Japan: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
- 11.5.10. Genomic Data Set for Real World Evidence (RWE) Applications Market - Malaysia
- 11.5.10.1. Malaysia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
- 11.5.10.2. Malaysia.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
- 11.5.10.3. Malaysia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
- 11.5.10.4. Malaysia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
- 11.5.10.5. Malaysia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
- 11.5.10.6. Malaysia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
- 11.5.11. Genomic Data Set for Real World Evidence (RWE) Applications Market - Indonesia
- 11.5.11.1. Indonesia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
- 11.5.11.2. Indonesia.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
- 11.5.11.3. Indonesia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
- 11.5.11.4. Indonesia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
- 11.5.11.5. Indonesia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
- 11.5.11.6. Indonesia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
- 11.5.12. Genomic Data Set for Real World Evidence (RWE) Applications Market - South Korea
- 11.5.12.1. South Korea: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
- 11.5.12.2. South Korea.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
- 11.5.12.3. South Korea: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
- 11.5.12.4. South Korea: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
- 11.5.12.5. South Korea: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
- 11.5.12.6. South Korea: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
- 11.6. Genomic Data Set for Real World Evidence (RWE) Applications Market - Middle East & Africa
- 11.6.1. Middle East & Africa: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
- 11.6.2. Middle East & Africa: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
- 11.6.3. Middle East & Africa: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
- 11.6.4. Middle East & Africa: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
- 11.6.5. Middle East & Africa: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
- 11.6.6. Middle East & Africa: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
- 11.6.7. Genomic Data Set for Real World Evidence (RWE) Applications Market - Saudi Arabia
- 11.6.7.1. Saudi Arabia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
- 11.6.7.2. Saudi Arabia.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
- 11.6.7.3. Saudi Arabia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
- 11.6.7.4. Saudi Arabia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
- 11.6.7.5. Saudi Arabia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
- 11.6.7.6. Saudi Arabia: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
- 11.6.8. Genomic Data Set for Real World Evidence (RWE) Applications Market - UAE
- 11.6.8.1. UAE: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
- 11.6.8.2. UAE.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
- 11.6.8.3. UAE: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
- 11.6.8.4. UAE: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
- 11.6.8.5. UAE: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
- 11.6.8.6. UAE: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
- 11.6.9. Genomic Data Set for Real World Evidence (RWE) Applications Market - Israel
- 11.6.9.1. Israel: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
- 11.6.9.2. Israel.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
- 11.6.9.3. Israel: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
- 11.6.9.4. Israel: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
- 11.6.9.5. Israel: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
- 11.6.9.6. Israel: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
- 11.6.10. Genomic Data Set for Real World Evidence (RWE) Applications Market - South Africa
- 11.6.10.1. South Africa: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
- 11.6.10.2. South Africa.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
- 11.6.10.3. South Africa: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
- 11.6.10.4. South Africa: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
- 11.6.10.5. South Africa: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
- 11.6.10.6. South Africa: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
- 11.7. Genomic Data Set for Real World Evidence (RWE) Applications Market - Latin America
- 11.7.1. Latin America: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
- 11.7.2. Latin America.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
- 11.7.3. Latin America: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
- 11.7.4. Latin America: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
- 11.7.5. Latin America: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
- 11.7.6. Latin America: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
- 11.7.7. Genomic Data Set for Real World Evidence (RWE) Applications Market - Mexico
- 11.7.7.1. Mexico: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
- 11.7.7.2. Mexico.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
- 11.7.7.3. Mexico: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
- 11.7.7.4. Mexico: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
- 11.7.7.5. Mexico: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
- 11.7.7.6. Mexico: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
- 11.7.8. Genomic Data Set for Real World Evidence (RWE) Applications Market - Brazil
- 11.7.8.1. Brazil: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
- 11.7.8.2. Brazil.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
- 11.7.8.3. Brazil: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
- 11.7.8.4. Brazil: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
- 11.7.8.5. Brazil: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
- 11.7.8.6. Brazil: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
- 11.7.9. Genomic Data Set for Real World Evidence (RWE) Applications Market - Argentina
- 11.7.9.1. Argentina: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Network Model, 2019-2032 (USD Million)
- 11.7.9.2. Argentina.: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Genomic Data Type, 2019-2032 (USD Million)
- 11.7.9.3. Argentina: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Spend, 2019-2032 (USD Million)
- 11.7.9.4. Argentina: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Patient Records, 2019-2032 (USD Million)
- 11.7.9.5. Argentina: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data typers, 2019-2032 (USD Million)
- 11.7.9.6. Argentina: Genomic Data Set for Real World Evidence (RWE) Applications Market, by Data type, 2019-2032 (USD Million)
12. Competitive Landscape
- 12.1. Expansion and Acquisition Analysis
- 12.1.1. Expansion
- 12.1.2. Acquisitions
- 12.2. Partnerships/Collaborations/Agreements/Exhibitions
13. Company Profiles
- 13.1. Caris Life Sciences
- 13.1.1. Company Overview
- 13.1.2. Financial Performance
- 13.1.3. Product Benchmarking
- 13.1.4. Recent Development
- 13.2. Foundation Medicine, Inc
- 13.2.1. Company Overview
- 13.2.2. Financial Performance
- 13.2.3. Product Benchmarking
- 13.2.4. Recent Development
- 13.3. Guardant Health
- 13.3.1. Company Overview
- 13.3.2. Financial Performance
- 13.3.3. Product Benchmarking
- 13.3.4. Recent Development
- 13.4. HealthVerity, Inc
- 13.4.1. Company Overview
- 13.4.2. Financial Performance
- 13.4.3. Product Benchmarking
- 13.4.4. Recent Development
- 13.5. Invitae Corporation
- 13.5.1. Company Overview
- 13.5.2. Financial Performance
- 13.5.3. Product Benchmarking
- 13.5.4. Recent Development
- 13.6. IQVIA Inc
- 13.6.1. Company Overview
- 13.6.2. Financial Performance
- 13.6.3. Product Benchmarking
- 13.6.4. Recent Development
- 13.7. Komodo Health, Inc
- 13.7.1. Company Overview
- 13.7.2. Financial Performance
- 13.7.3. Product Benchmarking
- 13.7.4. Recent Development
- 13.8. LabCorp
- 13.8.1. Company Overview
- 13.8.2. Financial Performance
- 13.8.3. Product Benchmarking
- 13.8.4. Recent Development
- 13.9. Myriad Genetics Inc
- 13.9.1. Company Overview
- 13.9.2. Financial Performance
- 13.9.3. Product Benchmarking
- 13.9.4. Recent Development
- 13.10. Natera, Inc
- 13.10.1. Company Overview
- 13.10.2. Financial Performance
- 13.10.3. Product Benchmarking
- 13.10.4. Recent Development
- 13.11. Ovation.io
- 13.11.1. Company Overview
- 13.11.2. Financial Performance
- 13.11.3. Product Benchmarking
- 13.11.4. Recent Development
- 13.12. TEMPUS
- 13.12.1. Company Overview
- 13.12.2. Financial Performance
- 13.12.3. Product Benchmarking
- 13.12.4. Recent Development
